Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for Genmab stock ranges from a low of $27 to a high of $48. The average analyst price target of $37.8 forecasts a 66.74% increase in the stock price over the next year.

Price Target: $37.80 (+66.74%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$27	$37.8	$37	$48
Change	+19.10%	+66.74%	+63.21%	+111.73%

* Price targets were last updated on Jul 8, 2025.

Analyst Ratings

The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	3	3	3	3	2	2
Buy	4	4	4	4	4	3
Hold	2	2	2	2	2	2
Sell	1	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	9	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $45 → $46	Strong Buy	Maintains	$45 → $46	+102.91%	Jul 8, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50 → $37	Strong Buy	Reiterates	$50 → $37	+63.21%	Apr 9, 2025
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $50 → $45	Strong Buy	Maintains	$50 → $45	+98.50%	Mar 11, 2025
Matt Phipps William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Mar 11, 2025
Jonathan Chang Leerink Partners	Leerink Partners	Hold → Buy Upgrades $27	Hold → Buy	Upgrades	$27	+19.10%	Feb 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.64B

Increased by 21.64%

from 2.99B

Revenue Next Year

4.20B

Increased by 15.57%

from 3.64B

EPS This Year

106.15

Increased by 530.06%

from 16.85

EPS Next Year

127.16

Increased by 19.79%

from 106.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.66B	1.29B	2.08B	2.44B	2.99B	3.64B	4.20B	4.80B
Revenue Growth	106.20%	-22.52%	61.88%	17.23%	22.32%	21.64%	15.57%	14.21%
EPS	11.87	6.85	11.87	9.79	16.85	106.15	127.16	156.10
EPS Growth	132.20%	-42.30%	73.29%	-17.49%	72.08%	530.06%	19.79%	22.76%
Forward PE	-	-	-	-	-	0.21	0.18	0.15
No. Analysts	-	-	-	-	-	27	26	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.1B	4.8B	5.3B
Avg	3.6B	4.2B	4.8B
Low	3.3B	3.7B	4.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	36.3%	33.0%	26.2%
Avg	21.6%	15.6%	14.2%
Low	11.1%	0.6%	-2.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	139.40	154.12	194.49
Avg	106.15	127.16	156.10
Low	81.78	94.71	114.90

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	727.4%	45.2%	52.9%
Avg	530.1%	19.8%	22.8%
Low	385.4%	-10.8%	-9.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.